Rajeev Dadoo

SR One

Rajeev joined SR One in 2003 and is now a Partner. He currently works with portfolio companies Adheron, IlluminOss Medical, True North Therapeutics, and SetPoint Medical. Rajeev has also been involved with SR One's investments in Cydex, Hypnion, iPierian, Inc., Predix Pharmaceuticals, Rib-X Pharmaceuticals, Octoplus, Trigen, Nucleonics, and Pinnacle Pharmaceuticals.

In addition to his role at SR One, Rajeev spent time with the Competitive Excellence group within GSK working on company-wide strategic projects for GSK's Corporate Executive Team.

Prior to SR One, Rajeev worked at Genentech, where his role included technology and clinical development, and at Bio-Rad Laboratories in a product development role. Rajeev worked at Genome Therapeutics in a business development role and earlier was a co-founder of Unimicro Technologies, a company that was created to develop and commercialize instrumentation for biomedical analysis.

Education, Personal, and Fellowship

Rajeev holds an MBA from the Wharton School of the University of Pennsylvania, a PhD in chemistry from Stanford University, and a BA in chemistry and mathematics from Knox College.

As a member of Fellows Class 9, Rajeev served his fellowship at SR One under the mentorship of Phil Smith.